Please assess the completion status of the following clinical trial:

Trial Title: Keloid Tissue Bank

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients must have clinically confirmed diagnosis of keloid~2. Signed consent form; parent or a legal guardian should consent for children and those under age of 18.~3. Have at least one paraffin block of excess keloid tissue that has been removed in the past; or is planned to be removed in future.~4. Able and willing to undergo a keloid biopsy (optional)~5. Able and willing to undergo biopsy of their normal appearing skin (optional, minimum age 18).~Exclusion Criteria:~1. Individuals who are mentally challenged, who cannot consent to participate in this study.~2. Psychological Illness that may result in non-compliance with the procedure and the required follow up.~3. Known allergy to lidocaine or other local anesthetics.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with keloid (Type: None): All patients will have a clinical diagnosis of keloid and will consent to participate in this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).